ATE311228T1 - Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel - Google Patents
Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxelInfo
- Publication number
- ATE311228T1 ATE311228T1 AT01307370T AT01307370T ATE311228T1 AT E311228 T1 ATE311228 T1 AT E311228T1 AT 01307370 T AT01307370 T AT 01307370T AT 01307370 T AT01307370 T AT 01307370T AT E311228 T1 ATE311228 T1 AT E311228T1
- Authority
- AT
- Austria
- Prior art keywords
- dmxaa
- docetaxel
- combinations
- paclitaxel
- anticancer combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01307370A EP1287854B1 (de) | 2001-08-30 | 2001-08-30 | Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE311228T1 true ATE311228T1 (de) | 2005-12-15 |
Family
ID=8182225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01307370T ATE311228T1 (de) | 2001-08-30 | 2001-08-30 | Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1287854B1 (de) |
AT (1) | ATE311228T1 (de) |
DE (1) | DE60115429T2 (de) |
DK (1) | DK1287854T3 (de) |
ES (1) | ES2252160T3 (de) |
SI (1) | SI1287854T1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008335469A1 (en) * | 2007-12-13 | 2009-06-18 | Novartis Ag | Combinations of therapeutic agents for treating cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9903404D0 (en) * | 1999-02-16 | 1999-04-07 | Angiogene Pharm Ltd | Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis |
JP2001247459A (ja) * | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | 癌の組み合わせ療法 |
-
2001
- 2001-08-30 SI SI200130499T patent/SI1287854T1/sl unknown
- 2001-08-30 AT AT01307370T patent/ATE311228T1/de active
- 2001-08-30 EP EP01307370A patent/EP1287854B1/de not_active Expired - Lifetime
- 2001-08-30 ES ES01307370T patent/ES2252160T3/es not_active Expired - Lifetime
- 2001-08-30 DK DK01307370T patent/DK1287854T3/da active
- 2001-08-30 DE DE60115429T patent/DE60115429T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60115429D1 (de) | 2006-01-05 |
DK1287854T3 (da) | 2006-04-03 |
SI1287854T1 (sl) | 2006-08-31 |
DE60115429T2 (de) | 2006-08-10 |
ES2252160T3 (es) | 2006-05-16 |
EP1287854B1 (de) | 2005-11-30 |
EP1287854A1 (de) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE415963T1 (de) | Zusammensetzungen aus dmxaa und anderen antikrebsmittel | |
DE60031268D1 (de) | Verfahren und zusammansetzung zur behandlung von krebs | |
RS20080167A (en) | Novel improved compositions for cancer therapy | |
BRPI0607017B8 (pt) | composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc | |
DE60228761D1 (de) | Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung | |
DE60237115D1 (de) | Synergistische Kombination von (-) -Gossypol mit Docetaxel oder Paclitaxel zur Behandlung von Krebs. | |
NO20044259L (no) | Topiske farmasoytiske sammensetninger inneholdende proantocyanidiner for behandling av dermatitt | |
ATE420117T1 (de) | Kovalent an hyaluronsäure oder dessen derivate gebundene taxane | |
DE60109632D1 (de) | Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung | |
BRPI0307808A2 (pt) | composição inibidora da lipase | |
DE69322912D1 (de) | Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E | |
ATE241376T1 (de) | Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten | |
DE60115429D1 (de) | Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel | |
UY27394A1 (es) | Pedidos con actividad anti- angiogéna. | |
PT1259502E (pt) | Analogos biologicamente activos da discodermolida | |
DE60111614D1 (de) | Taxan-derivate für die behandlung von krebs | |
CA2325041A1 (en) | Ultra-vit. plus | |
DE602004017425D1 (de) | Pmcol zur behandlung von prostatakrebs | |
BR0211762A (pt) | Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores | |
DE60102416D1 (de) | Sericin enthaltendes Mittel gegen Hautkrebs | |
DE602004002292D1 (de) | Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1287854 Country of ref document: EP |